Alzheimer's Vaccine
Araclon Biotech Advances in Its Innovative Vaccine and Diagnostic Test for Alzheimer's
Araclon Biotech
PR-M03-22-06Mar 15, 2022
Drug Development
Insmed Announces Positive Top-Line Results from Phase 2 WILLOW Study of INS1007 in Patients with Non-Cystic Fibrosis Bronchiectasis
Insmed
PR-M01-20-NI-048Feb 03, 2020
Clinical Trials
AIVITA Biomedical Announces Treatment of First Two Patients in Phase 2 Glioblastoma Trial
AIVITA Biomedical
PR-M11-18-NI-073-3354Nov 21, 2018
Phase II Results
Promising Phase 2 Results for Eye Implant from Genentech
Nice Insight
PAO-M08-18-NI-003Jul 31, 2018